Paper33650334
Current Use of Total Body Irradiation in Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation.
Jung J and 4 others. J Korean Med Sci, 2021. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Current Use of Total Body Irradiation in Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation. Papers, record 33650334. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33650334
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Current Use of Total Body Irradiation in Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Graft vs Host Disease | Major topic |
| Hematopoietic Stem Cell Transplantation | Major topic |
| Whole-Body Irradiation | Major topic |
| Cyclophosphamide | |
| Hematologic Neoplasms | |
| Humans | |
| Immunosuppressive Agents | |
| Recurrence | |
| Survival Rate | |
| Transplantation, Homologous |
Source PubMed
References66
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31394267 | Updated Clinical Outcomes of Hematopoietic Stem Cell Transplantation Using Myeloablative Total Body Irradiation with Ovarian Shielding to Preserve Fertility. | Biol Blood Marrow Transplant | 2019 | https://conductscience.org/library/papers/31394267 | PubMed |
| 2 | 23442062 | Comparison of total body irradiation plus cyclophosphamide with busulfan plus cyclophosphamide as conditioning regimens in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplant. | Leuk Lymphoma | 2013 | https://conductscience.org/library/papers/23442062 | PubMed |
| 3 | 24315843 | A phase II study of a nonmyeloablative allogeneic stem cell transplant with peritransplant rituximab in patients with B cell lymphoid malignancies: favorably durable event-free survival in chemosensitive patients. | Biol Blood Marrow Transplant | 2014 | https://conductscience.org/library/papers/24315843 | PubMed |
| 4 | 26130705 | Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia. | Blood | 2015 | https://conductscience.org/library/papers/26130705 | PubMed |
| 5 | 32110285 | Optimizing outcomes in relapsed/refractory Hodgkin lymphoma: a review of current and forthcoming therapeutic strategies. | Ther Adv Hematol | 2020 | https://conductscience.org/library/papers/32110285 | PubMed |
| 6 | 29893272 | Total Body Irradiation: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG). | Int J Radiat Oncol Biol Phys | 2018 | https://conductscience.org/library/papers/29893272 | PubMed |
| 7 | 31306219 | Comparison of outcomes after human leukocyte antigen-matched and haploidentical hematopoietic stem-cell transplantation for multiple myeloma. | Chin Med J (Engl) | 2019 | https://conductscience.org/library/papers/31306219 | PubMed |
| 8 | 30408564 | Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow Transplantation. | Biol Blood Marrow Transplant | 2019 | https://conductscience.org/library/papers/30408564 | PubMed |
| 9 | 29296834 | Haploidentical transplant in patients with myelodysplastic syndrome. | Blood Adv | 2017 | https://conductscience.org/library/papers/29296834 | PubMed |
| 10 | 30243581 | Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR Report. | Biol Blood Marrow Transplant | 2019 | https://conductscience.org/library/papers/30243581 | PubMed |
| 12 | 24065243 | Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI. | Blood | 2013 | https://conductscience.org/library/papers/24065243 | PubMed |
| 13 | 17317589 | Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia. | Biol Blood Marrow Transplant | 2007 | https://conductscience.org/library/papers/17317589 | PubMed |
| 14 | 2224134 | Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens. | Blood | 1990 | https://conductscience.org/library/papers/2224134 | PubMed |
| 15 | 30872371 | State-of-the-art review: allogeneic stem cell transplantation for myelofibrosis in 2019. | Haematologica | 2019 | https://conductscience.org/library/papers/30872371 | PubMed |
| 16 | 23370119 | Outcomes of related donor HLA-identical or HLA-haploidentical allogeneic blood or marrow transplantation for peripheral T cell lymphoma. | Biol Blood Marrow Transplant | 2013 | https://conductscience.org/library/papers/23370119 | PubMed |
| 17 | 30117176 | Optimal conditioning regimen for haplo-identical stem cell transplantation in adult patients with acquired severe aplastic anemia: Prospective de-escalation study of TBI and ATG dose. | Am J Hematol | 2018 | https://conductscience.org/library/papers/30117176 | PubMed |
| 18 | 25016195 | Nonmyeloablative peripheral blood haploidentical stem cell transplantation for refractory severe aplastic anemia. | Biol Blood Marrow Transplant | 2014 | https://conductscience.org/library/papers/25016195 | PubMed |
| 19 | 24747336 | Total body irradiation and cyclophosphamide plus antithymocyte globulin regimen is well tolerated and promotes stable engraftment as a preparative regimen before T cell-replete haploidentical transplantation for acute leukemia. | Biol Blood Marrow Transplant | 2014 | https://conductscience.org/library/papers/24747336 | PubMed |
| 20 | 26284307 | HLA haploidentical peripheral blood stem cell transplantation using reduced dose of posttransplantation cyclophosphamide for poor-prognosis or refractory leukemia and myelodysplastic syndrome. | Exp Hematol | 2015 | https://conductscience.org/library/papers/26284307 | PubMed |
| 21 | 28633038 | Hematopoietic cell transplantation for diffuse large B-cell and follicular lymphoma: Current controversies and advances. | Hematol Oncol Stem Cell Ther | 2017 | https://conductscience.org/library/papers/28633038 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41584606 | Multi-isocentric volumetric arc-based total body irradiation: radiation dose impact on oncological outcomes in patients receiving allogeneic hematopoietic cell transplantation. | Front Oncol | 2025 | https://conductscience.org/library/papers/41584606 | PubMed |
| 41010894 | Total Body Irradiation in Haematopoietic Stem Cell Transplantation: A Comprehensive Literature Review and Institutional Experience from the Policlinico of Catania. | Medicina (Kaunas) | 2025 | https://conductscience.org/library/papers/41010894 | PubMed |
| 34912605 | Does Total Body Irradiation Have a Favorable Impact on Thrombocyte Engraftment as per Neutrophil Engraftment in Allogeneic Stem Cell Transplantation? | Cureus | 2021 | https://conductscience.org/library/papers/34912605 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33650334
GET https://conductscience.org/api/papers/v1/33650334/references?page=2